288 related articles for article (PubMed ID: 19584409)
1. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
Collins GS; Altman DG
BMJ; 2009 Jul; 339():b2584. PubMed ID: 19584409
[TBL] [Abstract][Full Text] [Related]
2. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
[TBL] [Abstract][Full Text] [Related]
3. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
[TBL] [Abstract][Full Text] [Related]
4. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Brindle P
Heart; 2008 Jan; 94(1):34-9. PubMed ID: 17916661
[TBL] [Abstract][Full Text] [Related]
5. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
Collins GS; Altman DG
BMJ; 2010 May; 340():c2442. PubMed ID: 20466793
[TBL] [Abstract][Full Text] [Related]
6. Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
Collins GS; Altman DG
BMJ; 2012 Jun; 344():e4181. PubMed ID: 22723603
[TBL] [Abstract][Full Text] [Related]
7. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
[TBL] [Abstract][Full Text] [Related]
8. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.
Hippisley-Cox J; Coupland C; Robson J; Brindle P
BMJ; 2010 Dec; 341():c6624. PubMed ID: 21148212
[TBL] [Abstract][Full Text] [Related]
9. Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice.
de la Iglesia B; Potter JF; Poulter NR; Robins MM; Skinner J
Heart; 2011 Mar; 97(6):491-9. PubMed ID: 21097820
[TBL] [Abstract][Full Text] [Related]
10. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore.
Hippisley-Cox J; Coupland C; Robson J; Sheikh A; Brindle P
BMJ; 2009 Mar; 338():b880. PubMed ID: 19297312
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
[No Abstract] [Full Text] [Related]
12. Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited).
Tillin T; Hughes AD; Whincup P; Mayet J; Sattar N; McKeigue PM; Chaturvedi N;
Heart; 2014 Jan; 100(1):60-7. PubMed ID: 24186564
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease.
Ganz P; Heidecker B; Hveem K; Jonasson C; Kato S; Segal MR; Sterling DG; Williams SA
JAMA; 2016 Jun; 315(23):2532-41. PubMed ID: 27327800
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
Davis WA; Colagiuri S; Davis TM
Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
[TBL] [Abstract][Full Text] [Related]
15. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
Al-Shamsi S; Govender RD; King J
BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
[TBL] [Abstract][Full Text] [Related]
16. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
[TBL] [Abstract][Full Text] [Related]
17. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
[TBL] [Abstract][Full Text] [Related]
18. Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores.
Hippisley-Cox J; Coupland C
BMC Fam Pract; 2010 Jun; 11():49. PubMed ID: 20565929
[TBL] [Abstract][Full Text] [Related]
19. Marginal role for 53 common genetic variants in cardiovascular disease prediction.
Morris RW; Cooper JA; Shah T; Wong A; Drenos F; Engmann J; McLachlan S; Jefferis B; Dale C; Hardy R; Kuh D; Ben-Shlomo Y; Wannamethee SG; Whincup PH; Casas JP; Kivimaki M; Kumari M; Talmud PJ; Price JF; Dudbridge F; Hingorani AD; Humphries SE;
Heart; 2016 Oct; 102(20):1640-7. PubMed ID: 27365493
[TBL] [Abstract][Full Text] [Related]
20. Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.
Barroso LC; Muro EC; Herrera ND; Ochoa GF; Hueros JI; Buitrago F
Scand J Prim Health Care; 2010 Dec; 28(4):242-8. PubMed ID: 20873973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
